Carregant...

Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients

Although α-glucosidase inhibitors (AGIs) are commonly used for controlling postprandial blood glucose, AGIs-induced liver injuries have been reported. However, the relationship between AGIs and liver injuries in advanced chronic kidney disease (CKD) patients remains unexplored. In this nationwide ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kao, Chih-Chin, Wu, Pei-Chen, Wu, Che-Hsiung, Chen, Li-kwang, Chen, Hsi-Hsien, Wu, Mai-Szu, Wu, Vin-Cent
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707434/
https://ncbi.nlm.nih.gov/pubmed/26751038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep18996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!